Please provide your email address to receive an email when new articles are posted on . Patients with sickle cell disease experiencing chronic anemia reported improved quality of life after adding ...
Hosted on MSN
CT joins national push to open access to million-dollar sickle cell gene therapies through Medicaid
Breakthroughs in cell and gene therapy have opened the door to life-changing treatment for people with sickle cell disease. Yet few patients know these treatments exist, and even fewer can access them ...
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Hosted on MSN
From pain to possibility: Curing sickle cell disease
Sickle cell disease causes excruciating pain and damage to the body. But now there are new treatments that can put an end to patients’ suffering 'Ghost tapping' holiday scams on the rise 'They make up ...
One of the biggest quests in biology is understanding how every cell in an animal's body carries an identical genome yet ...
12hon MSN
Two white-blooded fish, two paths: Icefish and noodlefish independently lose red blood cell function
Antarctic icefish are famous for living without red blood cells, but they are not alone. A species of needle-shaped, ...
Dec. 8 (UPI) --The U.S. Food and Drug Administration on Monday announced the approval of the first hematopoietic stem cell transplant therapy to treat patients with rare but severe aplastic anemia.
The FDA has approved omidubicel-onlv (Omisirge, Gamida Cell Ltd.) as the first hematopoietic stem cell transplant therapy for patients with severe aplastic anemia (SAA). Specifically, omidubicel is ...
DUBLIN, IE AND LONDON, UK / ACCESS Newswire / December 5, 2025 / Ayrmid Ltd. ("Ayrmid" or the "Company"), the parent company of Gamida Cell Inc., a leader in cell therapy innovation announces that it ...
As 2025 comes to a close, the editors at The Scientist asked researchers to reflect on the biggest breakthroughs in cell biology this year. They named advances in everything from embryo models for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback